The Patent Finder

SCM Lifescience Co., Ltd.

5 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Sep 2031
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jun 24, 2027
    The maintenance fee for Pharmaceutical composition for preventing or treating hair loss comprising chemokine (C-X-C motif) ligand 1 (CXCL1) protein or CXCL1 protein and minoxidil as active ingredient (US 10,512,670) comes due Jun 24, 2027. Unpaid by Dec 27, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 5 of 5

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,439,929Treatment of graft-versus-host disease
In force
 · USPTO record
In forceUSPTO record
US 10,512,670Pharmaceutical composition for preventing or treating hair loss comprising chemokine (C-X-C motif) ligand 1 (CXCL1) protein or CXCL1 protein and minoxidil as active ingredient
In force
 · USPTO record
In forceUSPTO record
US 11,096,967Pharmaceutical composition for preventing or treating regulatory T cell-mediated diseases
In force
 · USPTO record
In forceUSPTO record
US 11,248,210Method for isolation of stem cells from bone marrow using subfractionation culturing method and proliferation thereof
In force
 · USPTO record
In forceUSPTO record
US 11,413,313Pharmaceutical composition for preventing or treating atopic dermatitis comprising clonal stem cells
In force
 · USPTO record
In forceUSPTO record
Also on record, not counted in the 5: 2 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 4 abandoned · 6 no status recorded

Showing 1 to 10 of 11, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/697,153Human Bone Marrow-Derived Mesenchymal Stem Cell Sheets and Methods for Their ProductionSep 30, 2022Pending
18/566,349Combined Administration Composition for Preventing or Treating Atopic Dermatitis, Comprising Function-Enhanced Stem Cells and Regulatory T CellsMay 30, 2022Abandoned
18/561,930Composition Containing Function-Reinforced Stem Cell for Prevention or Treatment of Atopic DermatitisMay 18, 2022Abandoned
18/259,130Dec 21, 2021No status recorded
17/791,096Composition for Reinforcing Function of Stem CellNov 24, 2020Abandoned
17/607,758Apr 27, 2020No status recorded
17/440,488Mar 18, 2020No status recorded
17/414,495Pharmaceutical Composition Comprising Clonal Stem Cells for Treating Graft-Versus-Host DiseaseDec 4, 2019Abandoned
17/413,641Dec 4, 2019No status recorded
16/331,426Sep 7, 2017No status recorded
10 of 11 applications shown.
Pro members see all 11 published applications.
Pro members: see all 11 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited